Kineta Gets $15M in New Cancer Drug Partnership with Pfizer

Seattle biotech company Kineta continues to expand its roster of drug development partners, announcing on Monday it has entered into a collaboration with Pfizer to develop therapies that use the body’s disease-fighting capabilities to attack cancerous tumors.